T529-15D3-2E5-4G12-1A7 [1A7, CTCC 10753]
CRL-3763 ™
The hybrid hybridoma cell lines 1B7 and 1A7 produce bispecific antibodies that recognize both the human Fc gamma receptor III (hFc gamma IIIR) and the multi-drug resistance antigen, P-glycoprotein. The 1B7 and the 1A7 antibodies are capable of binding to both the Fc receptors of cytotoxic cells, and tumor cells exhibiting multi-drug resistance phenotype, wherein the tumor cells over-express P-glycoproteins as compared to normal cells. These bispecific antibodies are useful in killing cancer cells.
This material is ATCC manufactured progeny of T529-15D3-2E5-4G12-1A7 [1A7, CTCC 10753] cited in US Pat No. US 6,143,873 as HB-10501